Bio-Path Holdings (BPTH)
(Real Time Quote from BATS)
$2.65 USD
-0.56 (-17.45%)
Updated Apr 23, 2024 03:58 PM ET
After-Market: $2.65 0.00 (0.00%) 4:16 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BPTH 2.65 -0.56(-17.45%)
Will BPTH be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BPTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BPTH
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
BPTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BPTH
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
12 Health Care Stocks Moving In Monday's Intraday Session
Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics among healthcare movers
SBFM, BPTH and INDO among pre-market losers